Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

Description

The purpose of this clinical trial is to compare the effectiveness of office-based methadone with pharmacy administration and/or dispensing to office-based buprenorphine for the treatment of opioid use disorder. This study will also examine factors influencing the implementation of office-based methadone.

Conditions

Opioid Use Disorder

Study Overview

Study Details

Study overview

The purpose of this clinical trial is to compare the effectiveness of office-based methadone with pharmacy administration and/or dispensing to office-based buprenorphine for the treatment of opioid use disorder. This study will also examine factors influencing the implementation of office-based methadone.

Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment - A Pragmatic Hybrid Effectiveness/Implementation Trial

Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

Condition
Opioid Use Disorder
Intervention / Treatment

-

Contacts and Locations

Oakland

Highland Hospital Bridge Clinic at Alameda Health System, Oakland, California, United States, 94602

San Francisco

Outpatient Buprenorphine Induction Clinic, University of California, San Francisco, San Francisco, California, United States, 94103

Denver

Rapid Start Clinic, Kaiser Permanente Colorado, Denver, Colorado, United States, 80205

Boston

Officed Based Addiction Treatment Program, Boston Medical Center, Boston, Massachusetts, United States, 02118

Minneapolis

Hennepin Healthcare Addiction Medicine, Minneapolis, Minnesota, United States, 55415

Huntington

Marshall University Division of Addiction Sciences P.R.O.A.C.T, Huntington, West Virginia, United States, 25703

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    18 Years to 99 Years

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    No

    Collaborators and Investigators

    Yale University,

    David Fiellin, MD, PRINCIPAL_INVESTIGATOR, Yale University

    Study Record Dates

    2029-05